Search results
Results from the WOW.Com Content Network
Methylhexanamine (also known as methylhexamine, 1,3-dimethylamylamine, 1,3-DMAA, dimethylamylamine, and DMAA; trade names Forthane and Geranamine) is an indirect sympathomimetic drug invented and developed by Eli Lilly and Company and marketed as an inhaled nasal decongestant from 1948 until it was voluntarily withdrawn from the market in the 1980s.
Dimethylethanolamine (DMAE or DMEA) is an organic compound with the formula (CH 3) 2 NCH 2 CH 2 OH. It is bifunctional, containing both a tertiary amine and primary alcohol functional groups. It is a colorless viscous liquid. It is used in skin care products for improving skin tone and also taken orally as a nootropic.
Antibiotic use was not associated with an increased risk of cognitive impairment and dementia in healthy older adults, according to a recent study.
Meanwhile, health care providers say the legacy of unwinding may not fully come into focus for years. “We have huge problems with chronic illness in adults that are costing the system a lot of ...
The flipside is also true: Avoid anything that seems to cause issues, for the time being, even if it’s considered healthy. Remember, everyone’s reactions to foods are different.
Other health problems compound the chronic complications of diabetes such as smoking, obesity, high blood pressure, elevated cholesterol levels, and lack of regular exercise. Complications of diabetes are a strong risk factor for severe COVID-19 illness.
Thatch explores the complex history of U.S. health care, from the Great Depression to the Affordable Care Act. Learn how key legislation shaped today's system and how innovations like ICHRAs are ...
Health policy and health systems can have impacts on deaths and thereby may also be a factor of deaths, also including for example education policy (e.g. health illiteracy), climate policy (e.g. future water scarcity impacts) and transportation policy (e.g. motor vehicle accidents, pollution and physical activity), [citation needed] as well as ...